EE Impact

Coloplast

Denmark · Pharma & Healthcare

LeaveRussia detail: Scaling Back

Scaling back

Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care.

Status last verified 03/08/2026Source checked 14/09/2023Company website ↗LeaveRussia profile ↗

Business in Russia

Commercial activity in Russia has been reduced and the organisation downsized.

Decision trail

Decision date 17/08/2023 · Reference ↗

Received revenues in Russia in 2021-2022. Coloplast’s priority is also on continuing our supply of products to our users. We provide essential products like ostomy bags and catheters that are necessary for people to maintain a dignified life. Our position is that under no circumstances should people living with intimate chronic conditions be without essential products and treatment. Since March 2022, Coloplast has, however, halted all new investments in Russia. Today, our focus is primarily on serving our existing users of ostomy products and catheters in the country.

Local stats (LeaveRussia)

Assets(RF), mln.USD
24
Capital(RF), mln.USD
16
Revenue(RF), mln.USD
35
Staff(RF), 2021
65
Taxes(RF), mln.USD
2
Glob.Revenue, mln.USD
3191

Status history since 2022

  1. 03/08/2026 scaling back · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.